Procter & Gamble (NYSE:PG – Get Free Report) updated its FY25 earnings guidance on Wednesday. The company provided earnings per share guidance of $6.91-$7.05 for the period, compared to the consensus earnings per share estimate of $6.94. The company issued revenue guidance of $85.72-$87.40 billion, compared to the consensus revenue estimate of $85.01 billion. Procter & Gamble also updated its FY 2025 guidance to 6.910-7.050 EPS.
Procter & Gamble Stock Up 0.9 %
PG stock opened at $166.20 on Friday. The stock has a market capitalization of $391.41 billion, a price-to-earnings ratio of 26.46, a price-to-earnings-growth ratio of 3.69 and a beta of 0.45. The company has a 50-day moving average of $168.97 and a two-hundred day moving average of $169.38. Procter & Gamble has a 52-week low of $152.06 and a 52-week high of $180.43. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.76 and a quick ratio of 0.55.
Procter & Gamble (NYSE:PG – Get Free Report) last released its earnings results on Wednesday, January 22nd. The company reported $1.88 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.86 by $0.02. The firm had revenue of $21.88 billion for the quarter, compared to analyst estimates of $21,657,595.49 billion. Procter & Gamble had a return on equity of 32.88% and a net margin of 18.35%. The company’s revenue was up 2.1% on a year-over-year basis. During the same quarter last year, the firm posted $1.84 EPS. As a group, equities research analysts anticipate that Procter & Gamble will post 6.94 EPS for the current year.
Procter & Gamble Announces Dividend
Analyst Ratings Changes
PG has been the topic of several recent research reports. Wells Fargo & Company lifted their price objective on Procter & Gamble from $176.00 to $180.00 and gave the stock an “overweight” rating in a report on Thursday. Morgan Stanley boosted their price target on shares of Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a report on Monday, October 21st. DA Davidson reaffirmed a “buy” rating and set a $209.00 price objective on shares of Procter & Gamble in a report on Thursday. Stifel Nicolaus upped their target price on shares of Procter & Gamble from $161.00 to $165.00 and gave the company a “hold” rating in a research note on Thursday. Finally, UBS Group dropped their price target on shares of Procter & Gamble from $196.00 to $189.00 and set a “buy” rating for the company in a research report on Thursday, January 16th. Eight investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, Procter & Gamble presently has a consensus rating of “Moderate Buy” and a consensus target price of $180.25.
Get Our Latest Report on Procter & Gamble
Insider Buying and Selling
In other Procter & Gamble news, insider Balaji Purushothaman sold 12,800 shares of the company’s stock in a transaction on Thursday, November 21st. The stock was sold at an average price of $172.73, for a total transaction of $2,210,944.00. Following the transaction, the insider now owns 11,595 shares of the company’s stock, valued at approximately $2,002,804.35. This represents a 52.47 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Gary A. Coombe sold 47,847 shares of the business’s stock in a transaction on Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total value of $8,604,804.48. Following the sale, the chief executive officer now owns 39,977 shares of the company’s stock, valued at approximately $7,189,463.68. The trade was a 54.48 % decrease in their position. The disclosure for this sale can be found here. 0.18% of the stock is owned by corporate insiders.
About Procter & Gamble
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Recommended Stories
- Five stocks we like better than Procter & Gamble
- Using the MarketBeat Dividend Tax Calculator
- 3 Buy-and-Hold Stocks for Long-Term Growth
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Despite Short-Term Risks Freeport McMoran Worth a Look
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- 3 Lean and Mean Stocks Generating Over $1M in Revenue Per Worker
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.